Pacific Biosciences of California, Inc.

NasdaqGS:PACB Stock Report

Market Cap: US$539.5m

Pacific Biosciences of California Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:PACB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Sep 24SellUS$34,065Susan KimIndividual19,782US$1.72
16 Sep 24SellUS$172,692Christian O. HenryIndividual98,907US$1.75
19 Aug 24SellUS$42,602Jeff EidelIndividual26,760US$1.59
16 Aug 24SellUS$63,174Mark Van OeneIndividual38,011US$1.66
20 May 24SellUS$10,708Michele FarmerIndividual5,275US$2.03
06 Mar 24BuyUS$176,160David MelineIndividual40,000US$4.40
04 Mar 24SellUS$69,056Christian O. HenryIndividual14,177US$4.87
04 Mar 24SellUS$25,695Susan KimIndividual5,275US$4.87
04 Mar 24SellUS$44,745Mark Van OeneIndividual9,186US$4.87
04 Mar 24SellUS$14,457Michele FarmerIndividual2,968US$4.87
20 Feb 24SellUS$481,320Christian O. HenryIndividual81,017US$5.96
20 Feb 24SellUS$138,403Susan KimIndividual23,327US$5.96
16 Feb 24SellUS$45,054Michele FarmerIndividual7,562US$5.96
16 Feb 24SellUS$92,337Jeff EidelIndividual15,498US$5.96
16 Feb 24SellUS$199,950Mark Van OeneIndividual33,560US$5.96
09 Jan 24SellUS$241,056Mark Van OeneIndividual31,012US$7.77

Insider Trading Volume

Insider Buying: PACB insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of PACB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,653,5730.557%
Hedge Funds16,443,6565.54%
Institutions278,964,64193.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.

Top Shareholders

Top 25 shareholders own 96.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.8%
Edmond de Rothschild Asset Management (France)
35,170,180US$69.3m110%0.77%
12.2%
ARK Investment Management LLC
33,406,401US$65.8m0.58%0.47%
8.67%
Nikko Asset Management Co., Ltd.
23,731,532US$46.8m87.7%0.02%
8.54%
Madrone Advisors, Llc
23,391,915US$46.1m0%8.18%
8.49%
BlackRock, Inc.
23,252,682US$45.8m-1.51%no data
7.47%
SoftBank Group Corp., Investment Arm
20,451,570US$40.3m0%1.33%
6.44%
The Vanguard Group, Inc.
17,642,804US$34.8m-32.1%no data
6%
Millennium Management LLC
16,443,656US$32.4m57.8%0.03%
5.48%
Edmond de Rothschild Asset Management (Luxembourg)
14,995,980US$29.5m0%6.42%
2.31%
Geode Capital Management, LLC
6,327,906US$12.5m3.69%no data
2.3%
Jackson Square Partners, LLC
6,296,116US$12.4m-29.1%1.03%
2.29%
State Street Global Advisors, Inc.
6,276,156US$12.4m5.74%no data
2.03%
BNY Asset Management
5,570,468US$11.0m-43.7%no data
1.38%
Morgan Stanley, Investment Banking and Brokerage Investments
3,784,213US$7.5m27.8%no data
1.28%
Madrone Capital Partners
3,500,000US$6.9m0%100.0%
1.24%
Capital Research and Management Company
3,390,000US$6.7m0%no data
0.98%
Jane Street Group, LLC, Asset Management Arm
2,671,269US$5.3m56.7%0.01%
0.86%
Northern Trust Global Investments
2,357,679US$4.6m-5.85%no data
0.8%
Goldman Sachs Group, Investment Banking and Securities Investments
2,193,058US$4.3m4.76%no data
0.77%
Marshall Wace LLP
2,121,920US$4.2m31.7%0.01%
0.77%
Soros Fund Management LLC
2,098,000US$4.1m23.6%0.11%
0.75%
Charles Schwab Investment Management, Inc.
2,040,303US$4.0m4.23%no data
0.74%
Goldman Sachs Asset Management, L.P.
2,029,067US$4.0m9.03%no data
0.73%
Bank of America Corporation, Asset Management Arm
2,006,572US$4.0m33.8%no data
0.67%
T. Rowe Price Group, Inc.
1,838,752US$3.6m-5.18%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pacific Biosciences of California, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luke SergottBarclays
Kyle MiksonCanaccord Genuity
Bryan BrokmeierCantor Fitzgerald & Co.